These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11515521)

  • 1. Selective cyclo-oxygenase inhibitors.
    Wilcock M; MacKenzie I
    Lancet; 2001 Aug; 358(9280):510. PubMed ID: 11515521
    [No Abstract]   [Full Text] [Related]  

  • 2. The COX 2 selective inhibitors: what the newspapers have not told you.
    Simon LS
    Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
    Hippisley-Cox J; Coupland C; Logan R
    BMJ; 2005 Dec; 331(7528):1310-6. PubMed ID: 16322018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of addressing the condition of nonsteroidal anti-inflammatory drug-related gastropathy.
    Cryer B
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S407-11. PubMed ID: 11570034
    [No Abstract]   [Full Text] [Related]  

  • 5. One hundred years of NSAID gastropathy: are coxibs the answer?
    Bjorkman DJ
    Rev Gastroenterol Disord; 2001; 1(3):121-7. PubMed ID: 12120179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drugs, cyclooxygenase inhibitors, and the risk of gastrointestinal complications.
    Cheskin LJ
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S395-6. PubMed ID: 11570030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Selective non-steroidal anti-inflammatory drug in a time of reasonable hopefulness].
    Letonturier P
    Presse Med; 2002 Sep; 31(31):1461. PubMed ID: 12395739
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-inflammatory non-steroidal selective cyclooxygenase 2 inhibitors and gastroduodenal lesions].
    Bannwarth B
    Presse Med; 2002 Sep; 31(31):1469-75. PubMed ID: 12395741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are selective COX 2 inhibitors superior to traditional NSAIDs? Both the CLASS and VIGOR trials support the COX 2 hypothesis.
    Stover RR
    BMJ; 2002 Jul; 325(7356):161; author reply 161. PubMed ID: 12134855
    [No Abstract]   [Full Text] [Related]  

  • 11. [NSAIDs for therapy of rheumatoid arthritis. Introduction].
    Takasaki Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():473-6. PubMed ID: 15799402
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current EULAR data on valdecoxib. New study results of gastrointestinal safety and "cost effectiveness"].
    Kellner H
    Krankenpfl J; 2004; 42(5-6):185. PubMed ID: 15527245
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe ulcers on celecoxib.
    Prescrire Int; 2002 Dec; 11(62):182-3. PubMed ID: 12472096
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin and NSAID sensitivity.
    Stevenson DD
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lumiracoxib reduces ulcer complications in comparison to NSAR].
    Z Orthop Ihre Grenzgeb; 2005; 143(2):158-9. PubMed ID: 15849631
    [No Abstract]   [Full Text] [Related]  

  • 16. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
    Strand V
    Lancet; 2007 Dec; 370(9605):2138-51. PubMed ID: 18156036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
    Joshua FF; Oakley SP; Major GA
    Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement.
    Hawkey CJ; Lanas AI;
    Am J Med; 2001 Jan; 110(1A):79S-100S. PubMed ID: 11166005
    [No Abstract]   [Full Text] [Related]  

  • 19. Upper gastrointestinal complications: the causes, consequences, and clinical outcomes.
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S397-401. PubMed ID: 11570031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are selective COX 2 inhibitors superior to traditional NSAIDs? Pharmacia's response to editorial.
    Geis GS
    BMJ; 2002 Jul; 325(7356):161; author reply 161. PubMed ID: 12134853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.